Are cannabinoid receptor knockout mice animal models for schizophrenia?

Area of Science:

• Neuroscience
• Genetics
• Psychiatry

Background:

• Schizophrenia is a prevalent psychiatric disorder requiring better diagnostic and therapeutic tools.
• Existing animal models offer limited insight into schizophrenia's complex pathophysiology.
• Cannabinoid receptor gene (CB1) knockout mice display behavioral parallels to schizophrenia symptoms.

Purpose of the Study:

• To investigate the role of the cannabinoid receptor gene (CB1) in schizophrenia.
• To explore the potential link between CB1 genetic alterations and schizophrenia etiology.
• To establish CB1 as a unifying candidate gene for various aspects of schizophrenic psychosis.

Main Methods:

• Analysis of behavioral alterations in CB1 knockout mice.
• Investigation of nucleotide homology between CB1 and dopamine D2 receptors.
• Examination of spirochaetal DNA insertion in the CB1 polyadenylation signal.

Main Results:

• CB1 knockout mice exhibit behavioral changes mirroring schizophrenia, cannabis intoxication, and dopamine D2 activation.
• A nucleotide homology between CB1 and D2 suggests a shared pathophysiological mechanism.
• Pre-inserted spirochaetal DNA on the CB1 polyadenylation signal is identified as a potential etiological factor.

Conclusions:

• Mutations in the 3' regulatory domain of CB1, analogous to thalassaemia, disrupt gene expression and information processing.
• CB1 acts as a unifying candidate gene, linking cannabis-induced psychosis, information processing deficits, and prenatal Borna virus infection.
• This research highlights CB1's novel role in understanding schizophrenia's diverse clinical manifestations and potential origins.